Navigation Links
GenVec Appoints Cynthia Collins as President and CEO
Date:5/21/2012

tant time in the Company's history," said Cynthia Collins. "I look forward to working with the Board and the rest of the management team to maximize the value of our product pipeline and related technologies. GenVec's novel treatment for hearing loss and balance disorders, partnered with Novartis AG, is on its path towards the commencement of human clinical trials and we will work together to see that our human and animal vaccine programs continue to progress.  We will also continue the sound strategy of partnering selected programs to maintain GenVec's strong financial position."

Ms. Collins received her undergraduate degree in microbiology in 1980 from the University of Illinois and her Masters in Business Administration from the University of Chicago Graduate School of Business in 1988.

About GenVecGenVec is a biopharmaceutical company using differentiated, proprietary technologies to create superior therapeutics and vaccines. A key component of our strategy is to develop and commercialize our product candidates through collaborations. GenVec is working with leading companies and organizations such as Novartis, Merial, and the U.S. Government to support a portfolio of product programs that address the prevention and treatment of a number of significant human and animal health concerns. GenVec's development programs address therapeutic areas such as hearing loss and balance disorders; as well as vaccines against infectious diseases including respiratory syncytial virus (RSV), herpes simplex virus (HSV), dengue fever, malaria, and human immunodeficiency virus (HIV). In the area of animal health we are developing vaccines against foot-and-mouth disease (FMD). Additional information about GenVec is available at www.genvec.com and in the Company's various filings with the Securities and Exchange Commission.

Statements herein relating to future financial or business performance, conditions or
'/>"/>

SOURCE GenVec, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. GenVec Announces Multiple Presentations at the American Society of Tropical Medicine and Hygiene Meeting
2. GenVec Receives National Cancer Institute Grant to Expand Cancer Program
3. GenVec Receives Second-Year Funding From SAIC for HIV and Influenza Vaccine Development
4. GenVec Reports Third Quarter 2010 Financial Results
5. GenVec Forms Collaboration With World-Leading Animal Health Company
6. GenVec Reports Fourth Quarter and 2010 Year-End Financial Results
7. GenVec to Host First Quarter 2011 Earnings Call and Webcast
8. GenVec Elects Adel A.F. Mahmoud and Edward M. Connor, Jr. to Board of Directors
9. GenVec Reports Second Quarter 2011 Financial Results
10. GenVec to Present at Stifel Nicolaus 2011 Healthcare Conference
11. GenVec to Release Third Quarter 2011 Financial Results and Conduct a Conference Call on November 9, 2011
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/22/2014)... 2014 Provectus Biopharmaceuticals, Inc. (NYSEMKT: PVCT) specializes ... investigational drug for cancer, is designed for injection into ... Its oncology focus is on melanoma, breast cancer and ... trials of PV-10 as a therapy for metastatic melanoma, ... dermatitis and psoriasis. This summer, the ...
(Date:10/22/2014)... and SHANGHAI , Oct. 22, 2014 ... FMI ) and WuXi PharmaTech (Cayman) Inc. (NYSE: ... offer Foundation Medicine,s comprehensive genomic profiling to biopharmaceutical companies ... Under the terms of the collaboration, ... the laboratory component of Foundation Medicine,s FoundationOne® assay at ...
(Date:10/20/2014)... , Oct. 20, 2014  Luoxis Diagnostics, Inc., ... AMPE), today announced that its academic collaborators will ... research potential for its novel RedoxSYS Diagnostic System, ... in the body in response to injury or ... ORP as a clinical marker will be presented ...
Breaking Medicine Technology:Provectus Biopharmaceuticals Looks at the Asian Markets: Analyst Coverage by Small Cap Traders 2Foundation Medicine and WuXi PharmaTech Announce Strategic Collaboration to Offer Best-in-Class Comprehensive Genomic Profiling in China 2Foundation Medicine and WuXi PharmaTech Announce Strategic Collaboration to Offer Best-in-Class Comprehensive Genomic Profiling in China 3Foundation Medicine and WuXi PharmaTech Announce Strategic Collaboration to Offer Best-in-Class Comprehensive Genomic Profiling in China 4Foundation Medicine and WuXi PharmaTech Announce Strategic Collaboration to Offer Best-in-Class Comprehensive Genomic Profiling in China 5Luoxis to Highlight RedoxSYS at Two Upcoming Scientific Conferences 2Luoxis to Highlight RedoxSYS at Two Upcoming Scientific Conferences 3Luoxis to Highlight RedoxSYS at Two Upcoming Scientific Conferences 4Luoxis to Highlight RedoxSYS at Two Upcoming Scientific Conferences 5
... June 20 Advocate Christ,Medical Center in Oak Lawn, ... the Chicago area, the only one in the Advocate ... are using a glue-like liquid for,the successful treatment of ... procedure, Thomas J. Grobelny MD, of,the medical center,s Neurosciences ...
... SYDNEY, Australia, June 19 /Xinhua-PRNewswire-FirstCall/ -- Pharmaxis,(ASX: PXS; ... the U.S. Food,and Drug Administration (FDA) have reached ... for bronchiectasis via the Special,Protocol Assessment process., ... a clinical trial protocol,intended to form the primary ...
Cached Medicine Technology:Advocate Christ Medical Center Using Glue-Like Liquid to Seal Off Brain Aneurysms 2Pharmaxis Concludes Special Protocol Assessment with FDA for Bronchitol Phase 3 Trial 2Pharmaxis Concludes Special Protocol Assessment with FDA for Bronchitol Phase 3 Trial 3
(Date:10/22/2014)... OR (PRWEB) October 22, 2014 During ... California’s fresh water supply runs dangerously low, Southern Oregon’s ... Southern Oregon’s rivers, despite the lowest mountain snow pack ... in late summer and early autumn.* That was the ... of the new book “Hiking Southern Oregon,” during an ...
(Date:10/22/2014)... 2014 Healthcare professionals who are ... education at home or on-the-go via laptops, tablets ... brand new, premium Seminar-on-Demand CE courses. The new ... 2,000 hours of CE course offerings, ... experience. With such a diverse library, there’s something ...
(Date:10/22/2014)... are only 24 hours in a day, that doesn’t seem to ... within their busy schedules for exercise and fitness. Fortunately, one does ... in shape. Here are five ways you can reach your fitness ... Your Commute , Consider riding a bike or taking the bus ... routine. If you must use your car to get to work, ...
(Date:10/22/2014)... PA (PRWEB) October 22, 2014 Richard ... as an industry leader with over 25 years experience. ... team leader in the areas related to EDI, B2B ... Carlson is an Editorial Advisory Board member for Pharmaceutical ... Educator. Blue Fin Group is a management and ...
(Date:10/22/2014)... HealthDay Reporter , TUESDAY, Oct. ... and length may be showing a genetic propensity for obesity ... genes have been linked to increased body fat, but the ... lean muscle, the researchers said. At 1 year, kids ... 2 and 3, however, these genes were linked to excessive ...
Breaking Medicine News(10 mins):Health News:Southern Oregon Is West’s Most Drought Proof Fresh Water Region Say Hiking Guide Authors 2Health News:Southern Oregon Is West’s Most Drought Proof Fresh Water Region Say Hiking Guide Authors 3Health News:Southern Oregon Is West’s Most Drought Proof Fresh Water Region Say Hiking Guide Authors 4Health News:Top Provider of Continuing Education at Home Releases 20 New Online Courses 2Health News:HealthGuideMD Presents Ways to Improve Your Exercise and Fitness 2Health News:Rich Carlson and Marc Duey to Hold Workshop at CBI’s Specialty Pharmacy and Distribution Networks Conference 2Health News:Tall, Heavy 1-Year-Olds May Be at Risk for Obesity Later, Study Finds 2
... , , OAKLAND, Calif., Dec. 7 ... Kaiser Permanente, has been named a 2010 Premier 100 IT ... from a broad range of companies recognized ... effectively managed IT strategies. , "Phil,s contributions have helped Kaiser ...
... , Amendment precludes use of federal dollars ... in Senate bill , Oppose making people pay for other people,s ... support for the Nelson-Hatch-Casey Amendment to the Senate health reform bill ... the position in a Dec. 7 letter to all U.S. senators, ...
... demonstrate a clear positive association between adolescent fitness and ... Southern California and colleagues in Sweden find that better ... on a range of intelligence tests and more ... adolescence and adulthood, the central nervous system displays considerable ...
... with the disease should be vaccinated along with other ... News) -- Swine flu is more likely than seasonal ... cell disease, a new study has found. , Johns ... 118 children with sickle cell disease treated for any ...
... , PLYMOUTH, Mich., Dec. 7 The Board of ... Mohsen Sohi will join the Management Board of Freudenberg & Co. ... Sost, who will be retiring. In his new role, Dr. Sohi ... , To assume this role, Dr. Sohi will leave his current ...
... , Group Offers ... WASHINGTON, Dec. 7 Opponents of health reform are fear-mongering ... the lobbying messages of the insurance industry. While the public ... delay a vote, the messages being delivered during that debate ...
Cached Medicine News:Health News:Kaiser Permanente CIO Philip Fasano Named One of Computerworld's Top 100 IT Leaders for 2010 2Health News:U.S. Bishops Urge Senators to Support Nelson-Hatch-Casey Amendment on Health Care Reform; Urge Constituents to Back it 2Health News:U.S. Bishops Urge Senators to Support Nelson-Hatch-Casey Amendment on Health Care Reform; Urge Constituents to Back it 3Health News:U.S. Bishops Urge Senators to Support Nelson-Hatch-Casey Amendment on Health Care Reform; Urge Constituents to Back it 4Health News:U.S. Bishops Urge Senators to Support Nelson-Hatch-Casey Amendment on Health Care Reform; Urge Constituents to Back it 5Health News:Fit teenage boys are smarter 2Health News:Swine Flu Can Batter Kids With Sickle Cell 2Health News:Freudenberg-NOK CEO Accepts New Position 2Health News:Senate Opponents Delivering 'Chicken Little' Mistruths Crafted to Sow Fear on Health Reform, says Consumer Watchdog 2Health News:Senate Opponents Delivering 'Chicken Little' Mistruths Crafted to Sow Fear on Health Reform, says Consumer Watchdog 3Health News:Senate Opponents Delivering 'Chicken Little' Mistruths Crafted to Sow Fear on Health Reform, says Consumer Watchdog 4Health News:Senate Opponents Delivering 'Chicken Little' Mistruths Crafted to Sow Fear on Health Reform, says Consumer Watchdog 5
Provides 30% more magnification and twice the field of view. Adjustable focus, with insufflator bulb....
Features a built-in throat illuminator, providing 30% more magnification and twice the field of view. Adjustable focus....
... Novus Spectra photocoagulator delivers power and ... solid-state (DPSS) technology. Diode side-pumping technology ... the compact Novus Spectra system, and ... beam output and system reliability from ...
A standard, durable and reliable indirect....
Medicine Products: